rBIO Achieves Crucial Milestone on Mission to Lower the Cost of Insulin by 30%

Just one year after successfully demonstrating lab-scale production of human insulin using synthetic biology techniques, rBIO recently concluded a successful optimization project with Washington University in St. Louis, and firms its path toward commercialization and large-scale production. SAN DIEGO, May 3, 2022 /PRNewswire/ — rBIO, an early-stage synthetic biology company focused on reducing the cost of